Best Medication for Failure to Thrive
There is no FDA-approved medication specifically indicated for failure to thrive (FTT), and the primary treatment is enhanced nutrition and addressing underlying causes rather than pharmacologic intervention. 1, 2
Context-Dependent Approach
The "best medication" depends entirely on the underlying etiology and patient population:
In Children with FTT
- No medication is recommended as first-line therapy 1, 2
- The most common cause is inadequate caloric intake, which requires nutritional intervention, not pharmacologic treatment 1, 2
- Cyproheptadine may be considered in underweight children with poor appetite, as it increases caloric intake, serum IGF-I concentration, and growth velocity over 4 months 3
- However, diagnostic testing and medication use should be reserved for severe malnutrition, high-risk conditions, or when initial nutritional treatment fails 1
In Older Adults with Unintentional Weight Loss
When pharmacologic intervention is warranted after addressing reversible causes:
- Megestrol acetate improves appetite and body weight but causes primarily adipose (not muscle) gain, with risks of thromboembolism, edema, and adrenal suppression 4, 5
- Mirtazapine shows promise for increasing appetite and weight in older adults, though it lacks FDA indication for this use 5, 6
- Dronabinol is another option used off-label as an appetite stimulant 5
In Cancer-Associated Cachexia
Based on ASCO 2020 guidelines:
- Megestrol acetate is the primary pharmacologic option for improving appetite and weight 4
- Corticosteroids improve appetite similarly to megestrol acetate but should be limited to 1-3 weeks in patients with life expectancy of weeks to months due to toxicities including muscle wasting, insulin resistance, and infections 4
- Olanzapine is NOT recommended outside clinical trials despite promising preliminary data, due to insufficient evidence 4
Critical Pitfalls to Avoid
- Do not prescribe appetite stimulants without first addressing underlying causes such as depression, pain, nausea, constipation, or medication side effects 4, 7
- Do not use corticosteroids long-term as myopathy and immunosuppression become manifest after a few weeks 4
- Be aware that megestrol acetate increases fat mass, not lean body mass, which may not improve functional outcomes 4
- Screen for eating disorders (avoidant/restrictive food intake disorder, anorexia nervosa) in older children before assuming simple inadequate intake 1
The Bottom Line
Enhanced nutrition with multidisciplinary support (nutritionist, occupational therapy, speech therapy) is the cornerstone of FTT treatment, not medication. 1, 2 Pharmacologic appetite stimulants should be considered only after optimizing nutrition and addressing reversible causes, with the specific agent chosen based on patient age, life expectancy, and underlying etiology.